Loading clinical trials...
Loading clinical trials...
An Evaluation of the Effect of the Erchonia® EVRL™ for Prescription Home Use Application in Providing Temporary Relief From Idiopathic Peripheral Neuropathy Foot Pain
Conditions
Interventions
Erchonia® EVRL™
Locations
1
United States
Franco & Co
Miramar, Florida, United States
Start Date
May 1, 2025
Primary Completion Date
May 16, 2027
Completion Date
June 16, 2027
Last Updated
September 8, 2025
NCT06752356
NCT07264426
NCT06920004
NCT07423390
NCT06792500
NCT06747351
Lead Sponsor
Erchonia Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions